title: Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.
authors.affiliation: University of Division of Communicable Diseases, Royal Free Hospital School of Medicine, London.
authors.forename: N
authors.initials: N
authors.lastname: Kennedy
authors.forename: R
authors.initials: R
authors.lastname: Fox
authors.forename: L
authors.initials: L
authors.lastname: Uiso
authors.forename: F I
authors.initials: FI
authors.lastname: Ngowi
authors.forename: S H
authors.initials: SH
authors.lastname: Gillespie
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D013636:Tanzania; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D002939:Ciprofloxacin